President-elect Donald J. Trump emphasized that the FDA has lost public trust and direction, and announced Dr. Martin A. Makary as a nominee for commissioner to address these issues.
Trump conveyed his confidence that Dr. Makary, known for advocating high-quality, lower-cost healthcare, would restore the FDA’s reputation and efficacy in medical research.
Dr. Makary has earned recognition for his critique of the medical establishment, focusing on enhancing patient safety and hospital practices, making him a controversial figure.
Robert F. Kennedy Jr. views the FDA as needing significant reform, advocating for firings of staff linked to suppressed treatments and criticizing funding from drug industry user fees.
Collection
[
|
...
]